News

A new edition of my migraine book and an upcoming conversation with Dr. Sanjay Gupta

June 7, 2026

Over the years I’ve seen many people with migraine who arrived in my office convinced that nothing would ever help. They had already tried multiple medications, procedures, and supplements. What they didn’t have was a clear plan and a realistic sense of what to expect.

This is why I keep updating The End of Migraines: 150 Ways to Stop Your Pain. The 3rd edition is now available and reflects what I’ve learned from treating thousands of patients, as well as newer options in migraine treatment that were not available when I wrote earlier editions.

The goal of the book has not changed: to give people living with migraine a practical, evidence‑informed guide they can actually use. It covers medications, neuromodulation devices, supplements, lifestyle changes, and ways of thinking about chronic pain that I see help in real life.

On June 12, I’ll be talking with Dr. Sanjay Gupta on his CNN podcast, Chasing Life, about migraines, why they are still under‑treated, and why I remain optimistic even for people who feel they have “tried everything.”

I asked Dr. Gupta’s producer how they found me. She replied that Dr. Gupta really appreciates doctors who have taken the time to write books, especially because of the time and effort it takes to grapple and crystallize all the learned and discovered knowledge.

Once the episode is live, I’ll post the link here. In the meantime, if you know someone who lives with migraine and feels stuck, you might consider sharing the new edition of the book with them.

Written by
Alexander Mauskop, MD
Continue reading
June 4, 2026
Research
A New Study of Meat Intake, Genetics, and Brain Health
A newly published Swedish study suggests that the relationship between diet and brain aging may be more genetically specific than previously understood. Researchers followed over 2,000 older adults for up to 15 years and found that higher meat consumption was associated with slower cognitive decline and lower dementia risk, but only in those carrying the APOE E4 genetic variant, the most common hereditary risk factor for Alzheimer's disease. This may be relevant for people with headaches.
Read article
June 3, 2026
News
Keynote address at the 22nd Annual Neuroscience Zappulla Research Day
I was honored to be delivering the keynote address at the 22nd Annual Neuroscience Zappulla Research Day on Wednesday, June 3, at the Hackensack Meridian Neuroscience Institute, JFK University Medical Center in Edison, NJ.
Read article
May 26, 2026
News
Why I Rarely Prescribe Topiramate, and What the New Data Shows
A new real-world study of 661 patients found that 67% stopped taking topiramate within six months, compared to 30% on candesartan. Candesartan also had a higher responder rate. Topiramate is FDA-approved; candesartan is not. The data makes the case for rethinking that priority.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe